Home Articles List Article Information
Journal of the Medical Research Institute
Journal Archive
Volume Volume 45 (2024)
Volume Volume 44 (2023)
Volume Volume 43 (2022)
Volume Volume 42 (2021)
Volume Volume 41 (2020)
Volume Volume 40 (2019)
Volume Volume 39 (2018)
Volume Volume 38 (2017)
Volume Volume 37 (2016)
Volume Volume 36 (2015)
Moussa, Y., Newairy, A., El-Rashidy, F., Gowayed, M., Kamel, M. (2024). The possible therapeutic effects of chlorogenic acid on experimental animal model of multiple sclerosis. Journal of the Medical Research Institute, 45(4), 28-42. doi: 10.21608/jmalexu.2024.343155.1041
yousra yousry Moussa; Al-Sayeda Al-sayed Newairy; Fatma El-Rashidy; Mennatallah Gowayed; Maher A Kamel. "The possible therapeutic effects of chlorogenic acid on experimental animal model of multiple sclerosis". Journal of the Medical Research Institute, 45, 4, 2024, 28-42. doi: 10.21608/jmalexu.2024.343155.1041
Moussa, Y., Newairy, A., El-Rashidy, F., Gowayed, M., Kamel, M. (2024). 'The possible therapeutic effects of chlorogenic acid on experimental animal model of multiple sclerosis', Journal of the Medical Research Institute, 45(4), pp. 28-42. doi: 10.21608/jmalexu.2024.343155.1041
Moussa, Y., Newairy, A., El-Rashidy, F., Gowayed, M., Kamel, M. The possible therapeutic effects of chlorogenic acid on experimental animal model of multiple sclerosis. Journal of the Medical Research Institute, 2024; 45(4): 28-42. doi: 10.21608/jmalexu.2024.343155.1041

The possible therapeutic effects of chlorogenic acid on experimental animal model of multiple sclerosis

Article 4, Volume 45, Issue 4, December 2024, Page 28-42  XML PDF (632.55 K)
Document Type: Review Article
DOI: 10.21608/jmalexu.2024.343155.1041
View on SCiNiTO View on SCiNiTO
Authors
yousra yousry Moussa email 1; Al-Sayeda Al-sayed Newairy1; Fatma El-Rashidy1; Mennatallah Gowayed2; Maher A Kamelorcid 3
1Biochemistry department, faculty of science, Alexandria University
2Department of Pharmacology & Toxicology, Faculty of Pharmacy and Drug Manufacturing, Pharos University in Alexandria.
3Department of Biochemistry, Medical Research Institute, Alexandria University, Alexandria, Egypt
Abstract
Multiple Sclerosis (MS) is an inflammatory neurodegenerative disease with distinctive features of focal demyelination, axonal loss, activation of glial cells, and immune cells infiltration. The symptoms of this disease are the consequence of the formation of new lesions in the central nervous system (CNS) and the expansion and aggravation of existing lesions causes its progression. MS can occur in four clinical forms with the relapsing-remitting form (RRMS) being the most prevalent among MS patients. RRMS is identified by the relapsing periods which are acute attacks followed by the remission periods where partial or full recovery takes place. The efficiency of current therapeutic approaches for MS is usually limited by the side effects. Chlorogenic acid (CA) is a natural compound found in a wide range of plant materials and is used in the prevention of many diseases. This review presents preclinical evidence that supports the use of CA in MS treatment protocols.
Keywords
multiple sclerosis; chlorogenic acid; oxidative stress
Main Subjects
Cellular and molecular biochemistry
Statistics
Article View: 43
PDF Download: 72